A Covid-19 vaccine trial in Binghamton, New York. The delays in vaccine development weighed on drugs stocks in Hong Kong and China on Wednesday. Photo: AP A Covid-19 vaccine trial in Binghamton, New York. The delays in vaccine development weighed on drugs stocks in Hong Kong and China on Wednesday. Photo: AP
A Covid-19 vaccine trial in Binghamton, New York. The delays in vaccine development weighed on drugs stocks in Hong Kong and China on Wednesday. Photo: AP
Hang Seng Index

Alibaba and Xiaomi hit record highs, but fail to boost Hong Kong, China markets

  • Hang Seng Index falls 0.3 per cent and Shanghai Composite declines 0.2 per cent
  • Delays in development of Cansino Biologics’ vaccine candidate affected sentiment earlier on

Topic |   Hang Seng Index
A Covid-19 vaccine trial in Binghamton, New York. The delays in vaccine development weighed on drugs stocks in Hong Kong and China on Wednesday. Photo: AP A Covid-19 vaccine trial in Binghamton, New York. The delays in vaccine development weighed on drugs stocks in Hong Kong and China on Wednesday. Photo: AP
A Covid-19 vaccine trial in Binghamton, New York. The delays in vaccine development weighed on drugs stocks in Hong Kong and China on Wednesday. Photo: AP
READ FULL ARTICLE